Price target upside
Arbutus Biopharma Corporation Price Target Upside or Downside
ABUS price target upside based on the current price and analyst average.
Direct answer
Arbutus Biopharma Corporation's analyst target implies +18.8%.
The average target is $5.55 compared with a recorded current price of $4.67.
This percentage is calculated from the verified average target and recorded market price.
Forecast evidence checked August 11, 2026.
Get free Arbutus Biopharma Corporation email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $4.67
- Average price target
- $5.55
- High price target
- $5.55
- Low price target
- $5.55
- Target upside
- +18.8%
- Consensus rating
- Strong Buy
- Analysts
- 1
- Evidence date
- August 11, 2026
- Valid through
- August 18, 2026